Errik Anderson | Boston

Mr. Anderson is a bioengineer, entrepreneur and investor who has founded or co-founded seven venture backed biotech companies in the last 20 years including Adimab, Alloy Therapeutics, Compass Therapeutics, Alector, Arsanis and Avitide. He is the currently the founder and CEO of Alloy Therapeutics and the founder and CEO of Ulysses Diversified Holdings where he supports entrepreneurially-minded people building for-profit companies that make the world a better place.

Mr. Anderson started his career in venture capital at Lehman Brothers Venture Capital and worked at Bristol-Myers Squibb in marketing. He received his MBA from the Tuck School of Business where he graduated as a Tuck Scholar. He studied Bioengineering as a graduate student at the Thayer School of Engineering and received his AB in Economics from Dartmouth College. He is the Chairman of the Board of Governors at Major League Rugby and an owner of the Boston-based professional rugby team, The New England Free Jacks.
Close Menu